Tumor endothelial marker 7a molecules and uses thereof

Details for Australian Patent Application No. 2002303880 (hide)

Owner AMGEN, INC.

Inventors Oliner, Johnathan Daniel; Juan, Todd; Bass, Michael Brian

Agent Wrays

Pub. Number AU-A-2002303880

PCT Number PCT/US02/16639

PCT Pub. Number WO2002/097110

Priority 60/293,852 25.05.01 US

Filing date 28 May 2002

Wipo publication date 9 December 2002

Event Publications

12 December 2002 Complete Application Filed

  Priority application(s): 60/293,852 25.05.01 US

8 May 2003 Application Open to Public Inspection

  Published as AU-A-2002303880

10 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002303881-Plate and method for high throughput screening

2002303879-Novel human hydroxylases and polynucleotides encoding the same